Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL34607 | 0.97 | ALDH1A1 (0.32) | ALDH1A1SMN1; SMN2CYP3A4CYP2C9CYP2C19 | |
| Bromide SCHEMBL584440 | 0.94 | ALDH1A1 (0.31) | ALDH1A1SMN1; SMN2CYP3A4CYP2C9CYP2C19 | |
| Water SCHEMBL28212473 | 0.94 | ALDH1A1 (0.31) | ALDH1A1SMN1; SMN2CYP3A4CYP2C9CYP2C19 | |
| Bromide SCHEMBL584276 | 0.94 | ALDH1A1 (0.31) | ALDH1A1SMN1; SMN2CYP3A4CYP2C9CYP2C19 | |
| Hydrochloric Acid SCHEMBL819060 | 0.94 | ALDH1A1 (0.31) | ALDH1A1SMN1; SMN2CYP3A4CYP2C9CYP2C19 | |
| Bromide SCHEMBL25396186 | 0.94 | ALDH1A1 (0.31) | ALDH1A1SMN1; SMN2CYP3A4CYP2C9CYP2C19 | |
| Water SCHEMBL29258026 | 0.94 | ALDH1A1 (0.31) | ALDH1A1SMN1; SMN2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL4228173 | 0.94 | — | — | |
| Bromide SCHEMBL6882180 | 0.92 | ALDH1A1 (0.30) | ALDH1A1SMN1; SMN2CYP3A4CYP2C9CYP2C19 | |
| Silver SCHEMBL28022140 | 0.92 | ALDH1A1 (0.30) | ALDH1A1SMN1; SMN2CYP3A4CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250188048-A1 | METHOD FOR PREPARING 2,5-FURANDICARBOXYLIC ACID COMPOUND | JIANGSU CELLURANICS NEW MATERIAL TECHNOLOGY CO., LTD. (CN) | 2025-06-12 | — | — | US | claimed |
| EP-4477651-A1 | METHOD FOR PREPARING 2,5-FURANDICARBOXYLIC ACID COMPOUND | Jiangsu Celluranics New Material Technology Co., Ltd. (CN) | 2024-12-18 | — | — | EP | claimed |
| WO-2023169517-A1 | METHOD FOR PREPARING 2,5-FURANDICARBOXYLIC ACID COMPOUND | 江苏赛瑞克新材料科技有限公司 | 2023-09-14 | — | — | WO | claimed |
| US-20250188048-A1 | METHOD FOR PREPARING 2,5-FURANDICARBOXYLIC ACID COMPOUND | JIANGSU CELLURANICS NEW MATERIAL TECHNOLOGY CO., LTD. (CN) | 2025-06-12 | — | — | US | disclosed |
| EP-4477651-A1 | METHOD FOR PREPARING 2,5-FURANDICARBOXYLIC ACID COMPOUND | Jiangsu Celluranics New Material Technology Co., Ltd. (CN) | 2024-12-18 | — | — | EP | disclosed |
| CN-116768832-A | Preparation method of 2,5-furandicarboxylic acid compound | 江苏赛瑞克新材料科技有限公司 | 2023-09-19 | — | — | CN | disclosed |
| WO-2023169517-A1 | METHOD FOR PREPARING 2,5-FURANDICARBOXYLIC ACID COMPOUND | 江苏赛瑞克新材料科技有限公司 | 2023-09-14 | — | — | WO | disclosed |
| US-7273953-B2 | Process for producing arylamine | FUJIFILM FINECHEMICALS CO., LTD. (JP) | 2007-09-25 | — | — | US | disclosed |
| US-20060069287-A1 | Process for producing arylamine | FUJIFILM FINECHEMICALS CO., LTD. (JP) | 2006-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060069287-A1 | Process for producing arylamine | TYR, AADAC, AOC2 | ALDH1A1 747/4885SMN1; SMN2 4320/4885CYP3A4 87/4885 |
| US-20250188048-A1 | METHOD FOR PREPARING 2,5-FURANDICARBOXYLIC ACID COMPOUND | HPD, DPYD, PGD | ALDH1A1 624/4885SMN1; SMN2 4474/4885CYP3A4 432/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.